Long-acting injectable risperidone and hospital readmission: a mirror-image study using a national claim-based database in Taiwan.
Chang
Hui-Chih
HC
Tang
Chao-Hsiun
CH
Tsai
Shih-Jen
SJ
Yen
Feng-Chang
FC
Su
Kusn-Pin
KP
D014150:Antipsychotic Agents / Q000008:administration & dosage* / Q000009:adverse effects / Q000191:economics; D003362:Cost-Benefit Analysis; D003692:Delayed-Action Preparations; D006295:Health Resources / Q000191:economics / Q000706:statistics & numerical data; D006801:Humans; D007273:Injections, Intramuscular; D007902:Length of Stay / Q000191:economics / Q000706:statistics & numerical data; D010359:Patient Readmission / Q000191:economics / Q000706:statistics & numerical data*; D018967:Risperidone / Q000008:administration & dosage* / Q000009:adverse effects / Q000191:economics; D012559:Schizophrenia / Q000188:drug therapy* / Q000191:economics; D013624:Taiwan; D014600:Utilization Review
D014150:Antipsychotic Agents; D003692:Delayed-Action Preparations; D018967:Risperidone